AI Workflow for COPD Exacerbation Prediction and Intervention

This workflow automates the high-cost, reactive cycle of COPD management by predicting exacerbations before they require emergency care. It ingests real-time respiratory rate, SpO2 from wearables, cough frequency from ambient microphones, and patient-reported symptoms via voice or app. The operational upside comes from reducing avoidable hospitalizations, which account for over 70% of COPD costs, while enabling proactive prescriptions and therapy scheduling. Implementation requires integrating with patient monitoring platforms like ResMed or Propeller Health and EHRs such as Epic or Cerner for clinical context and action routing.

The architecture centralizes on an orchestration engine, built with frameworks like LangGraph or Temporal, that applies personalized ML models to fused data streams. Key controls include confidence scoring for autonomous action, with low-confidence predictions routed to a clinician dashboard in platforms like TigerConnect or Slack. The system must handle data quality exceptions, manage approval gates for medication changes, and maintain a full audit trail for compliance. Rollout is phased, starting with a pilot cohort to validate prediction accuracy and intervention protocols before scaling.

The workflow begins with a real-time ingestion layer that normalizes streaming data from wearables (SpO2, respiratory rate), ambient sensors (cough frequency), and patient-reported outcomes via HL7/FHIR APIs from EHRs like Epic or Cerner. This data fusion creates a unified patient timeline, which is continuously scored by a dedicated prediction agent using a personalized risk model. Exceeding a configurable threshold triggers the orchestration engine, initiating a predefined intervention protocol without manual triage.

Implementation requires robust controls: all automated prescriptions and scheduling requests are routed through a mandatory human-in-the-loop approval gate within the clinician's EHR workflow before being committed. The entire process is logged by an audit layer for compliance and model performance monitoring. Rollout is sequenced by patient risk tier, starting with highest-acuity cohorts, and includes exception routing for data quality issues or conflicting clinical advice, ensuring safety and operational trust.

Phase 1 establishes the core predictive pipeline, ingesting real-time SpO2, respiratory rate, and patient-reported dyspnea scores via HL7/FHIR from connected devices and patient apps. A lightweight orchestration layer, built on LangGraph, runs a validated risk-scoring model, flagging high-risk patients for immediate nurse review in the EHR (Epic, Cerner) dashboard. This initial 8-week sprint delivers actionable alerts while enforcing a mandatory human-in-the-loop gate, building clinical trust and validating data quality before autonomous actions are introduced.

Phase 2 introduces conditional automation, where approved high-risk cases trigger autonomous e-prescriptions for rescue medications via Surescripts and schedule respiratory therapy sessions, with alerts sent to the patient and their pulmonologist. Phase 3 focuses on operational scaling, adding comprehensive observability for model drift, intervention efficacy, and exception routing. The entire architecture is designed for incremental validation, with each phase's success metrics—reduced ER visits, faster intervention time—governing the rollout of the next.

Clinical automation demands rigorous governance. The workflow must embed approval gates for medication triggers, integrate with Epic or Cerner for clinician review, and maintain a full audit trail of all AI-driven recommendations and actions. This control layer is non-negotiable for patient safety, regulatory compliance, and clinician trust, directly reducing liability and enabling defensible, scaled operations.

Rollout must be phased, starting with a pilot cohort where all AI recommendations are shadowed by clinicians without direct action. Success metrics—like reduced exacerbation-related ER visits—are tracked before granting the system limited autonomy. Implementation integrates with existing RPM platforms and care management workflows, ensuring the new logic layer augments rather than disrupts clinical operations, securing adoption and measurable ROI.

This workflow automates the detection and management of COPD exacerbation risk by continuously analyzing respiratory rate, SpO2 from wearables, cough frequency via ambient microphones, and patient-reported breathlessness. It replaces manual chart reviews and reactive care with a proactive, data-driven system. The operational upside comes from preventing costly hospitalizations through earlier intervention—automated rescue medication prescriptions, scheduled respiratory therapy, and prioritized pulmonologist alerts—which improves patient outcomes and reduces total cost of care.

Implementation requires a microservices architecture integrating with EHRs like Epic or Cerner via FHIR APIs, wearable vendor SDKs, and telephony for patient outreach. The core orchestration, built with LangGraph, manages state, executes multi-step actions, and enforces approval gates. Critical controls include confidence thresholding for automated prescriptions, mandatory clinician review for high-severity alerts, and comprehensive audit trails for all model predictions and interventions. Data quality pipelines must handle sensor dropout and normalize signals across device types before risk scoring.